Our Team

Built by clinicians and entrepreneurs who understand both the science and the commercial challenge.

SHAARPEC brings together Harvard Medical School faculty, multi-exit health tech entrepreneurs, and deep healthcare finance expertise — united around a single mission: giving pharma commercial teams earlier, more accurate intelligence.

The people building SHAARPEC

Tom Arneman
Tom Arneman
Chief Executive Officer
 

Multi-exit digital health entrepreneur and Entrepreneur in Residence at the Mass General Brigham digital innovation team. Tom leads company strategy, business development, and investor relations.

Philip Anderson
Philip Anderson, MD
Chief Medical Officer
 

Emergency medicine physician and Assistant Professor at Harvard Medical School, with a clinical appointment at Mass General Brigham. Philip leads scientific strategy, client engagement, and the design of SHAARPEC's trajectory-based analytics platform.

Thomas Davidsson
Thomas Davidsson
Chief Operating Officer
 

Swedish digital health entrepreneur with a background in finance and economics. Thomas oversees operations, international expansion, and the company's strategic partnerships across the EU and US markets.

Sal Renzo
Sal Renzo
Chief Business Officer
 

Healthcare finance, strategy, and M&A leader with deep private equity experience. Sal drives SHAARPEC's commercial growth strategy, investor engagement, and financial operations.

FE
Farzaneh Etminani, PhD
Lead Data Scientist
 

PhD researcher and faculty member with expertise in AI, machine learning, and predictive modeling applied to healthcare data. Farzaneh is the intellectual architect of SHAARPEC's trajectory modeling methodology.

HMS
Harvard Medical School & Mass General Brigham faculty
 
$2B+
Combined exit experience across health tech ventures
 
RWE
Pilot validation underway with a major pharma commercialization partner